You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 5,859,021


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,859,021
Title: Antiviral combinations
Abstract:Combinations comprising a compound of formula (1) ##STR1## or a pharmaceutically acceptable derivative thereof and an inhibitor of HIV replication, pharmacetical formulations thereof and their use in the treatment of HIV infections.
Inventor(s): Cameron; Janet Mary (Greenford, GB), Cammack; Nicholas (Greenford, GB)
Assignee: Glaxo Group Limited (Greenford, GB)
Application Number:08/605,610
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,859,021: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, potential infringement, and strategic value. This article will delve into the details of United States Patent 5,859,021, providing a step-by-step guide on how to analyze its scope and claims, and how to navigate the broader patent landscape.

Understanding Patent Scope and Claims

What is Patent Scope?

The scope of a patent is defined by its claims, which outline the specific aspects of the invention that are protected by the patent. The claims are the legal boundaries that distinguish the patented invention from prior art and other inventions[4].

What are Patent Claims?

Patent claims are the heart of a patent document, specifying what the inventor considers to be the novel and non-obvious aspects of the invention. These claims must be clear, concise, and supported by the description and drawings in the patent document[4].

Locating and Accessing the Patent

Using USPTO Resources

To analyze United States Patent 5,859,021, you can use the USPTO's Patent Public Search tool. This tool provides enhanced access to prior art and allows users to search for patents using various criteria such as patent number, title, and inventor[1].

Steps to Access the Patent

  1. Visit the USPTO Website: Go to the USPTO's Patent Public Search page.
  2. Enter the Patent Number: Input the patent number, 5,859,021, into the search bar.
  3. Review the Patent Document: Once the patent is located, review the abstract, background, summary, and detailed description of the invention.

Analyzing the Claims

Claim Structure

Patent claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[4].

Claim Analysis

  • Identify Independent Claims: These claims define the broadest scope of the invention.
  • Analyze Dependent Claims: These claims narrow down the scope by adding additional limitations.
  • Understand Claim Language: Pay attention to the specific terms and phrases used in the claims, as these define the protected invention.

Understanding the Patent Landscape

Global Dossier

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices. This can help in understanding the global patent family and any office actions related to the patent[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application. This helps in visualizing the search results for the same invention produced by several offices on a single page[1].

International Patent Offices

To see if the invention has been patented abroad, refer to searchable databases provided by other international intellectual property offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Technical and Business Information

Technical Information

The patent document includes a detailed description of the invention, background information, and a summary of the invention. This technical information is crucial for understanding how the invention works and its potential applications[4].

Business Information

The patent document also includes business information such as applicant details, inventor details, and the status of the patent application. This information can be vital for business strategy and potential licensing or technology transfer opportunities[4].

Public Domain Considerations

Public Domain Information

Technology disclosed in a patent document may be in the public domain if the patent application has not been filed in a given country, the patent has not been granted, the patent term has expired, or the disclosed information is not covered by the claims[4].

"Technology disclosed in a patent document may be in the public domain if: ... The patent term has expired, or the patent has not been renewed ... The disclosed information is not covered by the claims"[4].

Practical Applications and Strategies

Avoiding Infringement

Conducting thorough searches and analyzing the claims of existing patents can help avoid infringement. This involves performing freedom-to-operate searches to ensure that your invention does not infringe on existing patents[4].

Identifying Potential Partners

Patent analysis can also help identify potential partners for licensing, technology transfer, or collaboration. By understanding the patent landscape, you can find entities that are actively developing similar technologies[4].

Improving Patent Drafting

Analyzing the claims and scope of existing patents can improve your own patent drafting. Understanding how to write clear and concise claims can enhance the validity and enforceability of your patent[4].

Key Takeaways

  • Understand the Claims: The claims define the scope of the patent and are crucial for determining what is protected.
  • Analyze the Patent Landscape: Use tools like Global Dossier and CCD to understand the global context of the patent.
  • Consider Public Domain Information: Be aware of what information is in the public domain and what is protected by the patent.
  • Strategic Use: Use patent analysis to avoid infringement, identify potential partners, and improve patent drafting.

FAQs

Q: How do I access the full text of a patent document?

A: You can access the full text of a patent document using the USPTO's Patent Public Search tool or by visiting the USPTO Public Search Facility.

Q: What is the difference between independent and dependent claims?

A: Independent claims define the broadest scope of the invention, while dependent claims further limit the independent claims by adding additional specifications.

Q: How can I determine if a patent has been granted in other countries?

A: Use international patent databases such as those provided by the EPO, JPO, and WIPO to search for patent applications and grants in other countries.

Q: What is the significance of the Common Citation Document (CCD)?

A: The CCD consolidates prior art cited by all participating offices for the family members of a patent application, allowing users to visualize search results on a single page.

Q: How can patent information be used for business strategy?

A: Patent information can be used to avoid duplication of effort, avoid infringement, check patentability, and identify potential partners for licensing or technology transfer.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Federal Register - Guidelines for Assessing Enablement in Utility Applications: https://unblock.federalregister.gov
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. WIPO - Using patent information for policy and business analysis: https://www.wipo.int/edocs/mdocs/pct/en/wipo_pct_nbo_09/wipo_pct_nbo_09_www_121096.pdf
  5. IP Mall - GLAXO GROUP LTD v. TEVA PHARMACEUTICALS USA: https://ipmall.law.unh.edu/sites/default/files/hosted_resources/Markman/pdfFiles/2009.04.30_GLAXO_GROUP_LTD_v._TEVA_PHARMACEUTICALS_USA.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,859,021

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,859,021

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9110624May 16, 1991
United Kingdom9121381Oct 08, 1991
United Kingdom9123581Nov 06, 1991

International Family Members for US Patent 5,859,021

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0513917 ⤷  Subscribe C980018 Netherlands ⤷  Subscribe
European Patent Office 0513917 ⤷  Subscribe SPC/GB98/019 United Kingdom ⤷  Subscribe
European Patent Office 0513917 ⤷  Subscribe 98C0018 Netherlands ⤷  Subscribe
European Patent Office 0513917 ⤷  Subscribe 98C0020 Belgium ⤷  Subscribe
European Patent Office 0513917 ⤷  Subscribe 17/1998 Austria ⤷  Subscribe
Austria 131730 ⤷  Subscribe
Australia 1627992 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.